We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. In this double-blind trial, we randomly ...

For the aspirin comparison, the primary outcome was death from cardiovascular causes ... with a daily polypill comprising 40 mg of simvastatin, 100 mg of atenolol, 25 mg of hydrochlorothiazide ...

4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse clinical ...

Context. Aspirin has been clearly established as an important therapy in the secondary prevention of cardiovascular disease (CVD), and also plays a role in primary prevention. Objective.

The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial showed that the DPI (a combination of rivaroxaban at 2.5 mg twice daily [vascular dose] and ASA at 100 mg once ...

The use of aspirin as a primary prevention for atherosclerotic cardiovascular disease (ASCVD ... were treated with higher doses of aspirin (>100 mg/d) and lower doses of aspirin (≤ 100 mg ...

Medindia neither buys nor sells drugs. Aspirin (Aspin (100 mg)) is an analgesic and antipyretic, prescribed for pain, heart attack and fever. The drug decreases the substances that cause pain and ...

A study examining aspirin doses of 150 to 160 mg and 75 mg for preeclampsia prevention found no clinically important difference between groups.

Folks without a history of heart attacks or stroke may want to reconsider using aspirin as primary prevention for cardiovascular disease, says the Food and Drug Administration (FDA) in a new ...

The Company, with its lead products VAZALORE 81 mg and ... of cardiovascular events for millions of patients,” said Natasha Giordano, President & CEO of PLx Pharma. “Aspirin remains the ...